Bioprocess Filtration

Bioprocess Filtration Market Outlook

The global bioprocess filtration market is projected to reach USD 12.49 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2025 to 2035. Factors driving this robust growth include the increasing demand for biopharmaceutical products, the expansion of research activities in biotechnology, and a rising focus on water and wastewater treatment solutions. Additionally, advancements in filtration technologies and an increasing preference for single-use systems in bioprocessing are anticipated to bolster market growth. The ongoing global health crises and the resultant emphasis on vaccine production are further catalyzing the demand for efficient filtration systems.

Growth Factor of the Market

One of the primary growth factors for the bioprocess filtration market is the escalating need for high-purity biopharmaceuticals, which is compelling manufacturers to adopt advanced filtration solutions that can efficiently eliminate contaminants. The rise of biologics and biosimilars is reshaping the pharmaceutical landscape, leading to increased investments in bioprocessing infrastructure. Moreover, as regulatory requirements become more stringent regarding the quality and safety of biopharmaceuticals, companies are investing in sophisticated filtration systems to ensure compliance. The surge in biotechnological research, particularly in vaccine development, is another significant driver, as researchers require efficient filtration methods for various applications, from upstream processing to final product purification. Furthermore, the growing awareness of environmental sustainability is prompting industries to adopt bioprocess filtration techniques that minimize waste and maximize resource recovery.

Key Highlights of the Market

• The global bioprocess filtration market is expected to grow significantly, reaching USD 12.49 billion by 2035.
• Membrane filters are projected to dominate the product type segment due to their versatility and efficiency.
• The pharmaceutical industry is the largest application sector, accounting for a substantial share of the market.
• North America is anticipated to hold the largest market share, fueled by advanced biopharmaceutical research.
• Direct sales are becoming increasingly popular as they provide more control over the distribution process and customer engagement.

By Product Type

Membrane Filters:

Membrane filters are pivotal in the bioprocess filtration market, primarily due to their remarkable ability to separate particles based on size and shape. These filters are extensively utilized in various applications, including the clarification of liquids and the sterilization of heat-sensitive solutions. Their high filtration efficiency and versatility make them suitable for a plethora of bioprocessing stages, particularly in the pharmaceutical and biotechnology sectors. Furthermore, advancements in membrane technology have led to the development of specialized filters that can withstand high flow rates and offer enhanced permeability, catering to the evolving needs of bioprocessing facilities. This segment is witnessing significant growth driven by the demand for ultra-pure water and the increasing prevalence of sterile filtration in drug manufacturing.

Depth Filters:

Depth filters play a crucial role in the bioprocess filtration landscape, particularly suited for removing larger particulates and clarifying solutions. These filters are designed to trap particles within the thickness of the filter medium, allowing for high dirt-loading capacity and extended service life. They are commonly used in pre-filtration processes before membrane filtration, ensuring that the membrane operates efficiently and prolonging its life span. The versatility of depth filters makes them vital in industries such as food and beverage, where they are employed for wine and beer clarification. With the growing focus on quality control in food processing, the demand for depth filters is expected to grow, as they provide an effective solution for enhancing product purity.

Cartridge Filters:

Cartridge filters represent another significant product type in the bioprocess filtration market, known for their compact design and ease of replacement. These filters are widely used for various applications, including liquid clarification and particle removal in biopharmaceutical processes. Their modular design allows for scalability, making them ideal for both small-scale research settings and large-scale production facilities. The increasing preference for single-use systems in bioprocessing is further propelling the demand for cartridge filters, as they minimize cross-contamination risks. Additionally, advancements in materials and filter construction are enhancing the filtration efficiency and reliability of cartridge filters, thereby solidifying their position in the market.

Capsule Filters:

Capsule filters are gaining traction in the bioprocess filtration market due to their unique design that integrates the filter media within a pre-sterilized capsule. This design eliminates the need for additional assemblies, reducing the risk of contamination during filtration processes. Capsule filters are particularly advantageous in applications that require sterile filtration, such as culture media preparation and buffer filtration in biopharmaceutical manufacturing. With the rising emphasis on efficient and sterile processing, the demand for capsule filters is on the rise. Their ease of use, coupled with the ability to provide consistent filter performance, makes them an attractive option for many bioprocessing applications.

Filter Presses:

Filter presses are extensively used in large-scale bioprocessing facilities, particularly for solid-liquid separation processes. These systems are designed to handle high volumes of slurry, making them ideal for the pharmaceutical and biotechnology sectors. The ability to produce high-quality filtrates with minimal operator intervention is a significant advantage of filter presses. Furthermore, the growing focus on achieving higher yields and reducing production costs in bioprocessing is driving the adoption of filter presses, as they provide a cost-effective solution for large-scale operations. Innovations in filter press technology, including advancements in automated systems, are anticipated to further enhance their efficiency and market appeal.

By Application

Bioprocesses:

In the bioprocess filtration market, the bioprocesses segment plays a critical role as it encompasses various filtration applications essential for the production of biological products, including vaccines, therapeutics, and enzymes. Filtration is integral to upstream and downstream processing, facilitating the clarification and purification of biological materials. The increasing prevalence of biopharmaceuticals coupled with the necessity for stringent production standards drives the demand for efficient bioprocess filtration solutions. As the industry moves towards more automated and integrated bioprocessing systems, innovations in filtration technology are expected to provide enhanced performance, ensuring the delivery of high-quality products.

Pharmaceutical:

The pharmaceutical application segment represents one of the most significant sectors within the bioprocess filtration market. With the rise of biologics and biosimilars, there is an increasing demand for advanced filtration systems to ensure product purity and regulatory compliance. Filtration is a crucial step in drug manufacturing, where it serves to remove contaminants and particles that could impact product quality. The stringent regulatory landscape emphasizes the need for reliable filtration techniques, driving investments in advanced filtration technologies. As the pharmaceutical industry continues to evolve, the demand for innovative filtration solutions tailored to specific drug formulations is expected to surge, providing ample opportunities for market growth.

Food and Beverage:

The food and beverage industry is increasingly recognizing the importance of bioprocess filtration, especially concerning quality assurance and product safety. Filtration technologies play a vital role in the clarification and stabilization of beverages, ensuring that the final products are free from unwanted particles and microorganisms. With the growing consumer demand for high-quality and safe food products, manufacturers are adopting advanced filtration solutions to meet compliance standards and maintain product integrity. The segment is witnessing significant growth driven by the increasing trend of clean label products, which require stringent filtration processes to ensure quality and flavor consistency.

Water and Wastewater Treatment:

Water and wastewater treatment applications are crucial segments in the bioprocess filtration market, driven by the increasing global emphasis on clean water accessibility and environmental sustainability. Filtration technologies are essential in removing impurities and contaminants from water sources, ensuring that treated water meets safety standards for various uses. The growing population and industrial activities are intensifying the pressure on water resources, leading to a rising demand for effective treatment solutions. As governments worldwide implement stringent regulations on wastewater discharge, the adoption of advanced filtration technologies for both industrial and municipal water treatment applications is expected to grow, fueling market expansion in this segment.

Others:

Other applications within the bioprocess filtration market include niche sectors where specialized filtration methods are required, such as research laboratories and biotechnological research institutions. These settings often necessitate the use of advanced filtration techniques to achieve specific separation and purification goals. The growing trend of personalized medicine and the increasing focus on research and development in life sciences are contributing to the demand for bespoke filtration solutions. As the bioprocess filtration market evolves, these other applications are poised to grow, offering opportunities for innovation and the development of tailored filtration products.

By Distribution Channel

Direct Sales:

Direct sales represent a significant distribution channel in the bioprocess filtration market, allowing manufacturers to engage directly with customers and streamline the purchasing process. This approach provides companies with greater control over their sales strategies and customer relationships, facilitating the delivery of tailored solutions that meet specific client needs. Direct sales also enable manufacturers to offer post-sales support and comprehensive service packages, enhancing customer satisfaction. As industries seek more personalized solutions and improved service experiences, the trend towards direct sales is expected to gain momentum, driving market growth in this distribution channel.

Distributor Sales:

Distributor sales continue to be a vital channel in the bioprocess filtration market, enabling manufacturers to reach wider audiences through established distribution networks. Distributors often possess extensive industry knowledge and relationships, making them invaluable partners for manufacturers looking to expand their market presence. This channel is particularly advantageous for companies that may not have the resources to maintain an extensive direct sales force. By leveraging distributors, manufacturers can benefit from localized support, streamlined logistics, and enhanced market penetration. As the demand for bioprocess filtration solutions continues to grow, the distributor sales channel is expected to remain a key contributor to overall market dynamics.

By Material

Polyethersulfone:

Polyethersulfone (PES) is a widely utilized material in the bioprocess filtration market, particularly valued for its thermal stability and chemical resistance. PES membranes are commonly employed in various filtration applications, including the separation and purification of biological fluids. Their unique properties allow for high flow rates and excellent filtration performance, making them ideal for use in biopharmaceutical manufacturing. The growing demand for high-quality filtration solutions, alongside the increasing complexity of bioprocessing, is driving the adoption of PES materials. As innovations continue to emerge in membrane technology, the application of PES in bioprocess filtration is expected to expand, offering enhanced efficiency and reliability.

Nylon:

Nylon is another important material in the bioprocess filtration market, known for its high mechanical strength and excellent permeability. Nylon membranes are frequently utilized in applications requiring low protein binding and consistent filtration performance, making them ideal for biopharmaceutical and industrial applications. The increasing focus on product purity and the growing need for efficient filtration methods are contributing to the rising demand for nylon-based filtration solutions. As manufacturers strive for higher yields and improved product quality, the adoption of nylon materials in bioprocess filtration is expected to grow, offering significant opportunities for suppliers and manufacturers alike.

Cellulose Acetate:

Cellulose acetate is a biocompatible and environmentally friendly material commonly used in the bioprocess filtration market. These membranes are particularly effective in applications involving the filtration of biological solutions, offering low adsorption characteristics that help preserve the integrity of sensitive biomolecules. The rising emphasis on sustainability in manufacturing processes is driving the demand for cellulose acetate membranes, as they contribute to greener practices in biopharmaceutical production. As the industry progresses towards more eco-friendly solutions, the application of cellulose acetate in bioprocess filtration is likely to expand, providing enhanced filtration capabilities without compromising environmental considerations.

Polypropylene:

Polypropylene is a versatile material widely used in the bioprocess filtration market due to its excellent resistance to a wide range of chemicals and low cost. Polypropylene filters are commonly employed in various applications, including pre-filtration and clarification processes. Their ability to withstand harsh operating conditions makes them suitable for diverse bioprocessing environments. The increasing demand for cost-effective filtration solutions in the biopharmaceutical and food and beverage industries is propelling the growth of polypropylene-based products. As manufacturers continue to focus on efficiency and cost reduction, the adoption of polypropylene materials in bioprocess filtration is expected to rise, offering significant market potential.

Others:

The others segment encompasses various alternative materials used in bioprocess filtration applications, including advanced composite materials and innovative polymer blends. These materials often offer unique properties that cater to specific filtration needs and challenges, enhancing the flexibility of bioprocessing systems. As the demand for customized solutions grows, manufacturers are investing in research and development to explore new materials that can deliver superior filtration performance. The continuous evolution of material technology is expected to drive innovation in the bioprocess filtration market, creating opportunities for companies that can offer specialized filtration solutions tailored to diverse applications.

By Region

North America is projected to hold the largest share of the bioprocess filtration market, driven by the presence of leading biopharmaceutical companies and extensive research activities in biotechnology. The region's advanced healthcare infrastructure, coupled with significant investments in research and development, is fueling the demand for bioprocess filtration solutions. Furthermore, the increasing focus on developing biologics and biosimilars, along with stringent regulatory requirements, are contributing to the growth of this market segment. The North American bioprocess filtration market is expected to grow at a CAGR of 9.1% from 2025 to 2035, reflecting the region's robust commitment to innovation and quality in biopharmaceutical manufacturing.

Europe is also a significant player in the bioprocess filtration market, characterized by a strong emphasis on pharmaceutical production and innovative biotechnological advancements. The region's stringent regulatory environment necessitates the use of sophisticated filtration technologies to ensure adherence to quality standards. As European countries invest in biopharmaceutical manufacturing and research facilities, the demand for bioprocess filtration solutions is expected to rise significantly. The European market is projected to hold a considerable share, with increasing collaboration between industry players and research institutions further driving growth. Overall, the regional dynamics of the bioprocess filtration market highlight a strong potential for expansion across both North America and Europe.

Opportunities

The bioprocess filtration market presents numerous opportunities for growth, particularly as the demand for biologics and biosimilars continues to increase. With the global biopharmaceutical industry expanding rapidly, there is a pressing need for innovative filtration solutions that can streamline production processes while ensuring product safety and efficacy. The rise of advanced therapies, such as gene and cell therapies, is further fueling the demand for specialized filtration methods that can cater to unique processing requirements. Additionally, as bioprocessing facilities seek to enhance efficiency and flexibility, there is an opportunity for manufacturers to develop versatile filtration systems that integrate seamlessly into existing workflows. This trend is likely to encourage investments in research and development, fostering innovations that can address emerging challenges in the bioprocess filtration space.

Moreover, the growing emphasis on sustainability and environmental responsibility in manufacturing processes is creating vast opportunities for companies that focus on eco-friendly filtration solutions. As industries strive to minimize their carbon footprint and reduce waste, the adoption of sustainable filtration technologies will become increasingly important. Companies that can offer biodegradable or recyclable filter materials and solutions that optimize resource usage will likely gain a competitive edge in the market. Additionally, the ongoing global focus on clean water initiatives and wastewater treatment presents substantial opportunities for bioprocess filtration applications, especially in regions facing water scarcity. The alignment of market trends with sustainability objectives opens new avenues for growth and innovation in the bioprocess filtration sector.

Threats

Despite the promising growth prospects in the bioprocess filtration market, several threats could impede progress. One of the primary concerns is the rapid pace of technological advancements, which can lead to product obsolescence for companies that fail to keep up with innovation. As new filtration technologies emerge, existing solutions may be rendered less effective, resulting in decreased market share for those reliant on outdated systems. Additionally, the increasing focus on cost reduction in the biopharmaceutical sector may compel companies to seek less expensive, potentially lower-quality filtration solutions, which can undermine the overall market quality and performance standards. Moreover, the market's reliance on regulatory compliance can pose challenges, as companies must continuously adapt to evolving regulations and standards, increasing operational complexity and costs.

Another significant threat is the potential for economic downturns, which can result in reduced investments and spending across the biopharmaceutical and biotechnology sectors. Economic uncertainties may lead to budget constraints and decreased research funding, affecting the demand for bioprocess filtration equipment and solutions. Additionally, geopolitical factors and trade disputes could disrupt supply chains and hinder the availability of essential materials required for filtration products. As the market landscape continues to evolve, businesses must remain vigilant and proactive in addressing these potential threats to ensure sustained growth and competitiveness.

Competitor Outlook

• Merck KGaA
• Sartorius AG
• Pall Corporation
• 3M Company
• GE Healthcare
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Eaton Corporation
• Filtration Group Corporation
• Parker Hannifin Corporation
• Meissner Filtration Products
• Spartan Bioscience
• Toray Industries, Inc.
• Koch Membrane Systems
• W. L. Gore & Associates, Inc.

The competitive landscape of the bioprocess filtration market is characterized by a diverse array of established players, innovative startups, and research-based companies. Key industry participants are continually focusing on enhancing their product portfolios and investing in research and development to stay ahead in this rapidly evolving market. Collaborations, partnerships, and strategic acquisitions play a significant role in shaping the competitive dynamics, as companies seek to combine resources and expertise to offer comprehensive filtration solutions. As market demand rises, the competition among leading players is intensifying, leading to innovations that aim to improve filtration efficiency and accommodate an ever-growing range of applications.

Among the major companies in the bioprocess filtration market, Merck KGaA stands out for its extensive range of filtration products and solutions tailored for the biopharmaceutical industry. The company's commitment to research and development enables it to introduce cutting-edge filtration technologies, enhancing its competitive edge. Sartorius AG is another prominent player, recognized for its high-performance filtration systems that cater to various bioprocessing needs. The company emphasizes innovation and quality, establishing itself as a trusted partner for biopharmaceutical manufacturers. Pall Corporation, part of the Danaher Corporation, is well-regarded for its comprehensive filtration solutions and has a strong presence in the bioprocess filtration market, serving customers across multiple industries.

Thermo Fisher Scientific Inc. is also a key competitor, known for its extensive portfolio of filtration products and analytical technologies. The company's ability to leverage its broad expertise in scientific research allows it to address diverse customer needs effectively. GE Healthcare, a subsidiary of General Electric, offers a range of bioprocess filtration solutions, especially in the areas of vaccine and therapeutic manufacturing. The company’s focus on innovation and commitment to quality has positioned it as a leader in the bioprocess filtration market. As competition continues to evolve, these companies and others will play a vital role in driving advancements and shaping the future landscape of bioprocess filtration solutions.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Merck KGaA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Sartorius AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 GE Healthcare
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pall Corporation
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Eaton Corporation
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Spartan Bioscience
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Danaher Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Koch Membrane Systems
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Toray Industries, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Parker Hannifin Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Filtration Group Corporation
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Meissner Filtration Products
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 W. L. Gore & Associates, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bioprocess Filtration Market, By Material
    • 6.1.1 Polyethersulfone
    • 6.1.2 Nylon
    • 6.1.3 Cellulose Acetate
    • 6.1.4 Polypropylene
    • 6.1.5 Others
  • 6.2 Bioprocess Filtration Market, By Application
    • 6.2.1 Bioprocesses
    • 6.2.2 Pharmaceutical
    • 6.2.3 Food and Beverage
    • 6.2.4 Water and Wastewater Treatment
    • 6.2.5 Others
  • 6.3 Bioprocess Filtration Market, By Product Type
    • 6.3.1 Membrane Filters
    • 6.3.2 Depth Filters
    • 6.3.3 Cartridge Filters
    • 6.3.4 Capsule Filters
    • 6.3.5 Filter Presses
  • 6.4 Bioprocess Filtration Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Bioprocess Filtration Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bioprocess Filtration market is categorized based on

By Product Type

• Membrane Filters
• Depth Filters
• Cartridge Filters
• Capsule Filters
• Filter Presses

By Application

• Bioprocesses
• Pharmaceutical
• Food and Beverage
• Water and Wastewater Treatment
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material

• Polyethersulfone
• Nylon
• Cellulose Acetate
• Polypropylene
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Merck KGaA
• Sartorius AG
• Pall Corporation
• 3M Company
• GE Healthcare
• Danaher Corporation
• Thermo Fisher Scientific Inc.
• Eaton Corporation
• Filtration Group Corporation
• Parker Hannifin Corporation
• Meissner Filtration Products
• Spartan Bioscience
• Toray Industries, Inc.
• Koch Membrane Systems
• W. L. Gore & Associates, Inc.